Literature DB >> 21784644

Expression of N-myc downstream regulated gene 1 (NDRG1) in central neurocytoma.

Abbas Fotovati1, Samah Abu-Ali, Yasuo Sugita, Yasuhiro Nakamura.   

Abstract

N-myc downstream regulated gene 1 (NDRG1), also known as Cap43, Drg-1, and rit42, is expressed in various normal tissues and cancers, in which it is often associated with a favorable prognosis. It also plays a critical role in central nervous system development, with NDRG1 deficiency resulting in neural defects in mice. Central neurocytoma (CN) is a relatively rare tumor of the neurocytes in the brain, which occurs mainly in young adults. In the present study, we found that tissue samples from four patients with CN had both nuclear and cytoplasmic/membranous expression of NDRG1 protein in highly differentiated CN tumor cells. NDRG1 was also expressed in intratumoral microvessels. Immunohistochemical study of serial sections from the same patients revealed a marked association between the expression pattern of NDRG1 and that of neuron-specific enolase, a tumor differentiation marker. The data presented in this study suggest that NDRG1 could be considered a potential differentiation marker for CN.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21784644     DOI: 10.1016/j.jocn.2011.02.021

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  2 in total

1.  NDRG1 expression is related to the progression and prognosis of gastric cancer patients through modulating proliferation, invasion and cell cycle of gastric cancer cells.

Authors:  Xiaojing Chang; Xiaoyang Xu; Jinguo Ma; Xiaoying Xue; Zhenhua Li; Peng Deng; Shuanglong Zhang; Yu Zhi; Jing Chen; Dongqiu Dai
Journal:  Mol Biol Rep       Date:  2014-07-02       Impact factor: 2.316

2.  NDRG1 Controls Gastric Cancer Migration and Invasion through Regulating MMP-9.

Authors:  Xiaojing Chang; Xiaoyang Xu; Xiaoying Xue; Jinguo Ma; Zhenhua Li; Peng Deng; Jing Chen; Shuanglong Zhang; Yu Zhi; Dongqiu Dai
Journal:  Pathol Oncol Res       Date:  2016-05-06       Impact factor: 3.201

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.